Inari Medical (NARI)
(Delayed Data from NSDQ)
$40.63 USD
-0.61 (-1.48%)
Updated Oct 1, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for Inari Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 116 | 326 | 176 | 164 | 24 |
Receivables | 70 | 59 | 42 | 28 | 11 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 43 | 33 | 21 | 11 | 4 |
Other Current Assets | 6 | 5 | 6 | 3 | 0 |
Total Current Assets | 236 | 423 | 245 | 206 | 39 |
Net Property & Equipment | 21 | 22 | 16 | 8 | 3 |
Investments & Advances | 4 | 9 | 5 | 1 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 365 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 674 | 504 | 312 | 214 | 45 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 11 | 8 | 7 | 3 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 15 | 8 | 11 | 3 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 49 | 39 | 24 | 8 | 5 |
Total Current Liabilities | 76 | 56 | 43 | 14 | 9 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 36 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 19 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 66 | 0 | 1 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 209 | 87 | 72 | 14 | 30 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 54 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 504 | 463 | 257 | 228 | 2 |
Retained Earnings | -48 | -47 | -18 | -27 | -41 |
Other Equity | 9 | 1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 465 | 417 | 239 | 200 | 15 |
Total Liabilities & Shareholder's Equity | 674 | 504 | 312 | 214 | 45 |
Total Common Equity | 465 | 417 | 239 | 200 | -39 |
Shares Outstanding | 57.50 | 53.60 | 50.20 | 48.70 | NA |
Book Value Per Share | 8.09 | 7.78 | 4.77 | 4.11 | 0.00 |
Fiscal Year End for Inari Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 110 | 102 | 116 | 351 | 338 |
Receivables | 82 | 79 | 70 | 70 | 63 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 49 | 45 | 43 | 40 | 39 |
Other Current Assets | 9 | 8 | 6 | 8 | 5 |
Total Current Assets | 249 | 233 | 236 | 469 | 445 |
Net Property & Equipment | 23 | 21 | 21 | 21 | 21 |
Investments & Advances | 4 | 5 | 4 | 9 | 9 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 348 | 355 | 365 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 673 | 662 | 674 | 549 | 525 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 16 | 12 | 11 | 10 | 7 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 66 | 34 | 15 | 13 | 11 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 54 | 39 | 49 | 41 | 38 |
Total Current Liabilities | 138 | 86 | 76 | 66 | 58 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 35 | 35 | 36 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 45 | 66 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 249 | 215 | 209 | 97 | 89 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 529 | 518 | 504 | 497 | 484 |
Retained Earnings | -104 | -73 | -48 | -44 | -47 |
Other Equity | -1 | 2 | 9 | -1 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 424 | 447 | 465 | 452 | 436 |
Total Liabilities & Shareholder's Equity | 673 | 662 | 674 | 549 | 525 |
Total Common Equity | 424 | 447 | 465 | 452 | 436 |
Shares Outstanding | 58.20 | 58.10 | 57.50 | 57.50 | 57.30 |
Book Value Per Share | 7.28 | 7.70 | 8.09 | 7.86 | 7.60 |